Saint Louis, MO, United States
Park Avenue Compounding recalls
2 recalls recorded since 2018, most recently on 23 September 2025. 2 are listed as ongoing. Status and classification are as published by the FDA.
Recalls2
Ongoing (FDA)2
Terminated or completed0
Class I (FDA)0
Ongoing Class II Drugs
- Recall started
- 23 September 2025
- Reason
- CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
- Distribution
- Distributed in Missouri
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0178-2026
- Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.
Ongoing Class II Drugs
- Recall started
- 17 September 2025
- Reason
- CGMP Deviations
- Distribution
- MO
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0200-2026
- Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1.
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.